[WHITEPAPER] Rare Disease Fact Sheet – PRA Health Sciences

“Clinical development involving rare diseases poses a unique set of medical, scientific, and operational challenges. PRA understands these challenges and the critical success factors necessary to develop drugs for rare disease patients. It’s not a cookie-cutter formula, but rather a nimble approach that embraces the flexibility, creativity, and innovation needed to succeed in this arena. Since 2010, we have managed over 90 Phase I-IV rare disease trials in 10 therapeutic areas and contributed to the successful market approval of 14 drugs.”